Jefferson Capital, Inc. is gearing up for its IPO on the Nasdaq Global Select Market under the ticker JCAP. The offering comprises 10 million shares priced between $15 and $17, positioning this specialty finance IPO as a key event in Nasdaq IPO 2025. Investors are eyeing the strong growth in Jefferson Capital’s portfolio revenues and the backing of J.C. Flowers & Co.

Redfin and Rocket Companies have agreed to a major merger that could redefine digital real estate. Here's what investors and industry watchers need to know.

The aerospace and defense sector is buzzing with the upcoming AIRO Group Holdings IPO. Set to debut on the Nasdaq under the ticker "AIRO," this emerging growth company is aiming to raise capital through a 5 million share offering. Here's what investors need to know.

JBS, the global meat processing giant, is shaking up the financial world with its ambitious IPO strategy. The company is undergoing a major corporate restructuring to form JBS N.V., set for a dual listing on the New York Stock Exchange and Brazil’s B3 exchange. But what does this really mean for investors and stakeholders?

Caris Life Sciences, a pioneer in molecular diagnostics and AI-driven precision oncology, is gearing up to go public. With a multi-million-dollar IPO on the horizon, investors and analysts alike are taking a close look at the company’s financials, technology, and growth potential. Here’s your in-depth guide to the Caris IPO, ticker symbol CAI.

Slide Insurance Holdings, Inc. is stepping into the public markets with a tech-driven twist on traditional insurance. Here's a deep dive into everything you need to know about their upcoming IPO.

Ategrity Specialty Insurance Company Holdings is stepping into the public market spotlight with its 2025 IPO. Here's a quick breakdown of what investors should know about this emerging insurer and its ambitious NYSE listing under the ticker “ASIC.”

Voyager Technologies, Inc. is officially going public. With a promising offering and big names backing the launch, this IPO could shake up the tech investment landscape in 2025. Here's everything you need to know about the VOYG IPO.

Omada Health is officially stepping into the public market. With a proposed offering of 7.5 million shares and a mission to transform digital healthcare, investors are paying close attention. But is it the right move for your portfolio?

Chime Financial is set to hit the public markets with its 2025 IPO. Learn all the critical details from share structure to listing plans and more.

Fortive Corporation is officially spinning off Ralliant Corporation, a bold move to unlock new growth paths in the tech industry. Set to finalize on June 28, 2025, this strategic split offers investors distinct opportunities in precision technologies and connected workflow solutions. Here's the full scoop.

The fintech and crypto worlds are abuzz as Circle Internet Group, the firm behind the USDC stablecoin, prepares for a public debut. With heavy-hitting underwriters and strong institutional interest, this IPO could mark a turning point for regulated digital finance. Here's what investors need to know.

Helio Corporation is stepping up to the big leagues. With a newly filed IPO, the company is aiming to uplist from the OTC Pink Market to the NYSE American. Here’s everything you need to know about the offering, pricing, and what this move means for investors and the future of Helio.

Anthropic has become a rising star in the AI world, fueled by eye-popping valuations and powerhouse partnerships. But is an IPO on the horizon in 2025? Here’s a deep dive into where things stand, what investors should know, and how to get in early, if you qualify.

Figma is officially on its way to going public after its headline-grabbing $20 billion Adobe acquisition fell through. With explosive revenue growth, a wave of new AI tools, and a $17.84 billion valuation, here’s everything you need to know about Figma’s IPO journey.

MNTN, Inc. is stepping into the spotlight with its much-anticipated IPO. With a dual-class stock setup, big-name underwriters, and a bold market entrance plan, this offering has everyone talking. But before you dive into the hype, let’s dissect the fine print and get to the real story behind the numbers and structure.

Hinge Health has filed to go public, and it’s got Wall Street’s attention. With more than 13 million shares hitting the market and a projected price range of $28 to $32 per share, this tech-powered healthcare company is ready to scale its mission. From revenue model to voting structure and valuation potential, here's what you need to know about one of 2025’s most talked-about IPOs.

Stripe, one of the most valuable private fintech companies globally, continues to stir up investor speculation in 2025. With a fresh $91.5 billion valuation and confirmed profitability, all eyes are on whether the payments giant will finally go public or keep playing it private.

Nordstrom, once a fixture on public markets, is now officially private. As of May 2025, the Nordstrom family and Mexican retail giant El Puerto de Liverpool have wrapped up their all-cash $24.25/share acquisition. From deal details to strategic impacts, here’s the inside scoop.

OptiNose, Inc. is set to merge with Paratek Pharmaceuticals in a deal offering cash and CVR-based incentives. Here’s everything shareholders and market watchers need to know about the merger’s terms, timeline, and potential impact.